PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,633,000 | +798.6% | 453,524 | +583.4% | 0.09% | +615.4% |
| Q2 2022 | $293,000 | -80.7% | 66,360 | +45.4% | 0.01% | -90.6% |
| Q1 2021 | $1,520,000 | +146.8% | 45,633 | +92.1% | 0.14% | +113.8% |
| Q4 2020 | $616,000 | +83.9% | 23,754 | -36.4% | 0.06% | -13.3% |
| Q3 2016 | $335,000 | -28.4% | 37,342 | -54.1% | 0.08% | +41.5% |
| Q2 2015 | $468,000 | +377.6% | 81,300 | +383.9% | 0.05% | +430.0% |
| Q1 2015 | $98,000 | – | 16,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |